The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glucagon Injection Market Research Report 2024
Synopsis
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon Injection market is projected to reach US$ 870.2 million in 2029, increasing from US$ 575 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glucagon Injection market research.
The Glucagon injection market is driven by the rising prevalence of diabetes and hypoglycemia, and the growing awareness of the importance of emergency treatment for severe low blood sugar episodes. Glucagon injections are life-saving emergency medications used to rapidly raise blood sugar levels in individuals experiencing severe hypoglycemia. The rise in the global diabetic population and the need for effective management of insulin-related conditions contribute to market growth as glucagon injections offer a crucial solution in emergency situations. Moreover, advancements in device design and the development of user-friendly glucagon delivery systems have improved the accessibility and ease of administration. However, the market also faces challenges, including the need for patient education on proper administration and storage of glucagon injections, and the complexity of the regulatory landscape for medical emergency medications. Additionally, addressing affordability and expanding access to glucagon injections in various regions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable glucagon injection solutions, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and life-saving emergency treatments for hypoglycemia.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Glucagon Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals
Segment by Type
Vials
Prefilled
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glucagon Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon Injection market is projected to reach US$ 870.2 million in 2029, increasing from US$ 575 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glucagon Injection market research.
The Glucagon injection market is driven by the rising prevalence of diabetes and hypoglycemia, and the growing awareness of the importance of emergency treatment for severe low blood sugar episodes. Glucagon injections are life-saving emergency medications used to rapidly raise blood sugar levels in individuals experiencing severe hypoglycemia. The rise in the global diabetic population and the need for effective management of insulin-related conditions contribute to market growth as glucagon injections offer a crucial solution in emergency situations. Moreover, advancements in device design and the development of user-friendly glucagon delivery systems have improved the accessibility and ease of administration. However, the market also faces challenges, including the need for patient education on proper administration and storage of glucagon injections, and the complexity of the regulatory landscape for medical emergency medications. Additionally, addressing affordability and expanding access to glucagon injections in various regions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable glucagon injection solutions, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and life-saving emergency treatments for hypoglycemia.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Glucagon Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals
Segment by Type
Vials
Prefilled
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glucagon Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Glucagon Injection Market Overview
1.1 Product Overview and Scope of Glucagon Injection
1.2 Glucagon Injection Segment by Type
1.2.1 Global Glucagon Injection Market Value Comparison by Type (2023-2029)
1.2.2 Vials
1.2.3 Prefilled
1.3 Glucagon Injection Segment by Application
1.3.1 Global Glucagon Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Glucagon Injection Market Size Estimates and Forecasts
1.4.1 Global Glucagon Injection Revenue 2018-2029
1.4.2 Global Glucagon Injection Sales 2018-2029
1.4.3 Global Glucagon Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glucagon Injection Market Competition by Manufacturers
2.1 Global Glucagon Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Glucagon Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Glucagon Injection Average Price by Manufacturers (2018-2023)
2.4 Global Glucagon Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Glucagon Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucagon Injection, Product Type & Application
2.7 Glucagon Injection Market Competitive Situation and Trends
2.7.1 Glucagon Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucagon Injection Players Market Share by Revenue
2.7.3 Global Glucagon Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucagon Injection Retrospective Market Scenario by Region
3.1 Global Glucagon Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glucagon Injection Global Glucagon Injection Sales by Region: 2018-2029
3.2.1 Global Glucagon Injection Sales by Region: 2018-2023
3.2.2 Global Glucagon Injection Sales by Region: 2024-2029
3.3 Global Glucagon Injection Global Glucagon Injection Revenue by Region: 2018-2029
3.3.1 Global Glucagon Injection Revenue by Region: 2018-2023
3.3.2 Global Glucagon Injection Revenue by Region: 2024-2029
3.4 North America Glucagon Injection Market Facts & Figures by Country
3.4.1 North America Glucagon Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glucagon Injection Sales by Country (2018-2029)
3.4.3 North America Glucagon Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glucagon Injection Market Facts & Figures by Country
3.5.1 Europe Glucagon Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glucagon Injection Sales by Country (2018-2029)
3.5.3 Europe Glucagon Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucagon Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Glucagon Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glucagon Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Glucagon Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Glucagon Injection Market Facts & Figures by Country
3.7.1 Latin America Glucagon Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glucagon Injection Sales by Country (2018-2029)
3.7.3 Latin America Glucagon Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucagon Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucagon Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glucagon Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glucagon Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucagon Injection Sales by Type (2018-2029)
4.1.1 Global Glucagon Injection Sales by Type (2018-2023)
4.1.2 Global Glucagon Injection Sales by Type (2024-2029)
4.1.3 Global Glucagon Injection Sales Market Share by Type (2018-2029)
4.2 Global Glucagon Injection Revenue by Type (2018-2029)
4.2.1 Global Glucagon Injection Revenue by Type (2018-2023)
4.2.2 Global Glucagon Injection Revenue by Type (2024-2029)
4.2.3 Global Glucagon Injection Revenue Market Share by Type (2018-2029)
4.3 Global Glucagon Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Glucagon Injection Sales by Application (2018-2029)
5.1.1 Global Glucagon Injection Sales by Application (2018-2023)
5.1.2 Global Glucagon Injection Sales by Application (2024-2029)
5.1.3 Global Glucagon Injection Sales Market Share by Application (2018-2029)
5.2 Global Glucagon Injection Revenue by Application (2018-2029)
5.2.1 Global Glucagon Injection Revenue by Application (2018-2023)
5.2.2 Global Glucagon Injection Revenue by Application (2024-2029)
5.2.3 Global Glucagon Injection Revenue Market Share by Application (2018-2029)
5.3 Global Glucagon Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Glucagon Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novo Nordisk Glucagon Injection Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Glucagon Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly Glucagon Injection Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Glucagon Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fresenius Kabi Glucagon Injection Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Torrent Labs
6.4.1 Torrent Labs Corporation Information
6.4.2 Torrent Labs Description and Business Overview
6.4.3 Torrent Labs Glucagon Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Torrent Labs Glucagon Injection Product Portfolio
6.4.5 Torrent Labs Recent Developments/Updates
6.5 Amphastar Pharmaceuticals
6.5.1 Amphastar Pharmaceuticals Corporation Information
6.5.2 Amphastar Pharmaceuticals Description and Business Overview
6.5.3 Amphastar Pharmaceuticals Glucagon Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Amphastar Pharmaceuticals Glucagon Injection Product Portfolio
6.5.5 Amphastar Pharmaceuticals Recent Developments/Updates
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Corporation Information
6.6.2 Xeris Pharmaceuticals Description and Business Overview
6.6.3 Xeris Pharmaceuticals Glucagon Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Xeris Pharmaceuticals Glucagon Injection Product Portfolio
6.6.5 Xeris Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucagon Injection Industry Chain Analysis
7.2 Glucagon Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucagon Injection Production Mode & Process
7.4 Glucagon Injection Sales and Marketing
7.4.1 Glucagon Injection Sales Channels
7.4.2 Glucagon Injection Distributors
7.5 Glucagon Injection Customers
8 Glucagon Injection Market Dynamics
8.1 Glucagon Injection Industry Trends
8.2 Glucagon Injection Market Drivers
8.3 Glucagon Injection Market Challenges
8.4 Glucagon Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
